Antiretroviral Therapy Current Drugs

被引：167

作者：

Pau, Alice K. ^{[1
]}

George, Jomy M. ^{[2
]}

机构：

[1] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA

[2] Univ Sci Philadelphia, Philadelphia Coll Pharm, Dept Pharm Practice & Adm, Philadelphia, PA 19104 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2014年 / 28卷 / 03期

关键词：

HIV; Antiretroviral therapy; Nucleoside/nucleotide reverse transcriptase inhibitors; Non-nucleoside reverse transcriptase inhibitors; Protease inhibitors; Integrase strand transfer inhibitors; Fusion inhibitor; CCR5; antagonist; HIV-INFECTED PATIENTS; RITONAVIR-BOOSTED ATAZANAVIR; MYOCARDIAL-INFARCTION; RALTEGRAVIR; EFAVIRENZ; HYPERSENSITIVITY; EFFICACY; ABACAVIR; AIDS; OSTEOMALACIA;

D O I：

10.1016/j.idc.2014.06.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The rapid advances in drug discovery and the development of antiretroviral therapy is unprecedented in the history of modern medicine. The administration of chronic combination antiretroviral therapy targeting different stages of the human immunodeficiency virus' replicative life cycle allows for durable and maximal suppression of plasma viremia. This suppression has resulted in dramatic improvement of patient survival. This article reviews the history of antiretroviral drug development and discusses the clinical pharmacology, efficacy, and toxicities of the antiretroviral agents most commonly used in clinical practice to date.

引用

页码：371 / +

页数：33

共 61 条

[1]

[Anonymous], 2012, SINACOM 0625

[2]

[Anonymous], 2011, Panel on antiretroviral guidelines for adult and adolescents, P1

[3]

[Anonymous], 2012, HIV REPLICATION CYCL

[4] Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline [J].

Asahchop, Eugene L. ;

Wainberg, Mark A. ;

Oliveira, Maureen ;

Xu, Hongtao ;

Brenner, Bluma G. ;

Moisi, Daniela ;

Ibanescu, Ilinca R. ;

Tremblay, Cecile .

AIDS, 2013, 27 (06) :879-887

[5] Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study [J].

Bellini, C. ;

Keiser, O. ;

Chave, J-P ;

Evison, J. M. ;

Fehr, J. ;

Kaiser, L. ;

Weber, R. ;

Vernazza, P. ;

Bernasconi, E. ;

Telenti, A. ;

Cavassini, M. .

HIV MEDICINE, 2009, 10 (01) :12-18

[6] Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study [J].

Castagna, Antonella ;

Maggiolo, Franco ;

Penco, Giovanni ;

Wright, David ;

Mills, Anthony ;

Grossberg, Robert ;

Molina, Jean-Michel ;

Chas, Julie ;

Durant, Jacques ;

Moreno, Santiago ;

Doroana, Manuela ;

Ait-Khaled, Mounir ;

Huang, Jenny ;

Min, Sherene ;

Song, Ivy ;

Vavro, Cindy ;

Nichols, Garrett ;

Yeo, Jane M. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (03) :354-362

[7]

Cattelan Anna Maria, 2000, Journal of the National Cancer Institute Monographs, P44, DOI 10.1093/oxfordjournals.jncimonographs.a024256

[8] Intracranial Hemorrhage and Liver-Associated Deaths Associated with Tipranavir/Ritonavir: Review of Cases from the FDA's Adverse Event Reporting System [J].

Chan-Tack, Kirk M. ;

Struble, Kimberly A. ;

Birnkrant, Debra B. .

AIDS PATIENT CARE AND STDS, 2008, 22 (11) :843-850

[9] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].

CONNOR, EM ;

SPERLING, RS ;

GELBER, R ;

KISELEV, P ;

SCOTT, G ;

OSULLIVAN, MJ ;

VANDYKE, R ;

BEY, M ;

SHEARER, W ;

JACOBSON, RL ;

JIMENEZ, E ;

ONEILL, E ;

BAZIN, B ;

DELFRAISSY, JF ;

CULNANE, M ;

COOMBS, R ;

ELKINS, M ;

MOYE, J ;

STRATTON, P ;

BALSLEY, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180

[10] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].

Davey, RT ;

Bhat, N ;

Yoder, C ;

Chun, TW ;

Metcalf, JA ;

Dewar, R ;

Natarajan, V ;

Lempicki, RA ;

Adelsberger, JW ;

Millers, KD ;

Kovacs, JA ;

Polis, MA ;

Walker, RE ;

Falloon, L ;

Masur, H ;

Gee, D ;

Baseler, M ;

Dimitrov, DS ;

Fauci, AS ;

Lane, HC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114

← 1 2 3 4 5 6 7 →